Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
On Oct. 16, 2026, Viatris announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine…
On Oct. 16, 2026, Viatris announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine…